Wang Philip Li increased his holding of BIOHEART-B (02185) by 10,000 shares, with each share priced at 6.66 Hong Kong dollars.

15:09 01/12/2025

After increasing holdings, the latest number of shares held is 84,997,700 shares, with a shareholding ratio of 36.06%.

The latest data from the Hong Kong Stock Exchange shows that on November 27th, Wang Philip Li increased his holdings of BIOHEART-B (02185) by 10,000 shares at a price of 6.66 Hong Kong dollars per share, for a total amount of 66,000 Hong Kong dollars. After the increase, the latest holding number is 84.9977 million shares, and the shareholding ratio is 36.06%.

Fuan Pharmaceutical (300194.SZ): "Cefuroxime axetil granules" obtain drug registration certificate.

Shenma Industrial (600810.SH) has repurchased a cumulative 1.15% of its shares, spending 133 million yuan.

Chongqing Port plans to invest 299 million yuan in the second phase expansion project of Jiangjin Port to enhance its modern multimodal transportation capacity.

Fuan Pharmaceutical (300194.SZ): "Cefuroxime axetil granules" obtain drug registration certificate.

Shenma Industrial (600810.SH) has repurchased a cumulative 1.15% of its shares, spending 133 million yuan.

Chongqing Port plans to invest 299 million yuan in the second phase expansion project of Jiangjin Port to enhance its modern multimodal transportation capacity.